
Radiopharmaceutical - Global Market Outlook (2019-2027)
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Radiopharmaceutical Market, By Source
5.1 Introduction
5.2 Nuclear Reactors
5.3 Cyclotrons
6 Global Radiopharmaceutical Market, By Type
6.1 Introduction
6.2 Therapeutic
6.2.1 Alpha Emitters
6.2.2 Beta Emitters
6.2.3 Brachytherapy Isotopes
6.3 Diagnostic
6.3.1 Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
6.3.2 Positron Emission Tomography (PET) Radiopharmaceuticals
7 Global Radiopharmaceutical Market, By Radioisotope
7.1 Introduction
7.2 Yttrium-90
7.3 Thallium-201
7.4 Technetium-99
7.5 Strontium -89
7.6 Samarium-153
7.7 Rubidium-82
7.8 Rhenium-186
7.9 Radium-223
7.10 Palladium - 103
7.11 Leutetium-177
7.12 Iridium - 192
7.13 Iodine-131
7.14 Iodine-125
7.15 Iodine-123
7.16 Indium-111
7.17 Holmium-166
7.18 Gallium-68
7.19 Gallium-67
7.20 Fluorine-18
7.21 Fludeoxyglucose - (18F-FDG)
7.22 Erbium-169
7.23 Cesium-131
7.24 Actinium-225
8 Global Radiopharmaceutical Market, By Application
8.1 Introduction
8.2 Thyroid
8.3 Theranostics
8.4 Oncology
8.5 Neurology
8.6 Neuroendocrinology
8.7 Nephrology
8.8 Lymphoma
8.9 Inflammation
8.10 Gastroenterology
8.11 Cardiology
9 Global Radiopharmaceutical Market, By End User
9.1 Introduction
9.2 Ambulatory Surgical Centers
9.3 Cancer Research Institute
9.4 Diagnostic Imaging Centers
9.5 Hospitals
10 Global Radiopharmaceutical Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Lantheus Medical Imaging, Inc
12.2 GE Healthcare
12.3 Advanced Accelerator Applications
12.4 Mallinckrodt
12.5 Bayer AG
12.6 Siemens Healthineers
12.7 IBA Radiopharma Solutions
12.8 Eckert & Ziegler
12.9 Philips
12.10 Jubilant Life Sciences Limited
12.11 Novartis AG
12.12 BWX Technologies, Inc.
12.13 POLATOM
12.14 JSC Isotope
12.15 NTP Radioisotopes SOC Ltd
12.16 Curium
12.17 Australian Nuclear Science and Technology Organization (ANSTO)
12.18 Cardinal Health Inc.
12.19 Covidien Plc
12.20 Positron Corporation
12.21 Monrol Nuclear Products,Inc
12.22 Nordion,Inc.
List of Tables
1 Global Radiopharmaceutical Market Outlook, By Region (2018-2027) ($MN)
2 Global Radiopharmaceutical Market Outlook, By Source (2018-2027) ($MN)
3 Global Radiopharmaceutical Market Outlook, By Nuclear Reactors (2018-2027) ($MN)
4 Global Radiopharmaceutical Market Outlook, By Cyclotrons (2018-2027) ($MN)
5 Global Radiopharmaceutical Market Outlook, By Type (2018-2027) ($MN)
6 Global Radiopharmaceutical Market Outlook, By Therapeutic (2018-2027) ($MN)
7 Global Radiopharmaceutical Market Outlook, By Alpha Emitters (2018-2027) ($MN)
8 Global Radiopharmaceutical Market Outlook, By Beta Emitters (2018-2027) ($MN)
9 Global Radiopharmaceutical Market Outlook, By Brachytherapy Isotopes (2018-2027) ($MN)
10 Global Radiopharmaceutical Market Outlook, By Diagnostic (2018-2027) ($MN)
11 Global Radiopharmaceutical Market Outlook, By Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals (2018-2027) ($MN)
12 Global Radiopharmaceutical Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2018-2027) ($MN)
13 Global Radiopharmaceutical Market Outlook, By Radioisotope (2018-2027) ($MN)
14 Global Radiopharmaceutical Market Outlook, By Yttrium-90 (2018-2027) ($MN)
15 Global Radiopharmaceutical Market Outlook, By Thallium-201 (2018-2027) ($MN)
16 Global Radiopharmaceutical Market Outlook, By Technetium-99 (2018-2027) ($MN)
17 Global Radiopharmaceutical Market Outlook, By Strontium -89 (2018-2027) ($MN)
18 Global Radiopharmaceutical Market Outlook, By Samarium-153 (2018-2027) ($MN)
19 Global Radiopharmaceutical Market Outlook, By Rubidium-82 (2018-2027) ($MN)
20 Global Radiopharmaceutical Market Outlook, By Rhenium-186 (2018-2027) ($MN)
21 Global Radiopharmaceutical Market Outlook, By Radium-223 (2018-2027) ($MN)
22 Global Radiopharmaceutical Market Outlook, By Palladium - 103 (2018-2027) ($MN)
23 Global Radiopharmaceutical Market Outlook, By Leutetium-177 (2018-2027) ($MN)
24 Global Radiopharmaceutical Market Outlook, By Iridium - 192 (2018-2027) ($MN)
25 Global Radiopharmaceutical Market Outlook, By Iodine-131 (2018-2027) ($MN)
26 Global Radiopharmaceutical Market Outlook, By Iodine-125 (2018-2027) ($MN)
27 Global Radiopharmaceutical Market Outlook, By Iodine-123 (2018-2027) ($MN)
28 Global Radiopharmaceutical Market Outlook, By Indium-111 (2018-2027) ($MN)
29 Global Radiopharmaceutical Market Outlook, By Holmium-166 (2018-2027) ($MN)
30 Global Radiopharmaceutical Market Outlook, By Gallium-68 (2018-2027) ($MN)
31 Global Radiopharmaceutical Market Outlook, By Gallium-67 (2018-2027) ($MN)
32 Global Radiopharmaceutical Market Outlook, By Fluorine-18 (2018-2027) ($MN)
33 Global Radiopharmaceutical Market Outlook, By Fludeoxyglucose - (18F-FDG) (2018-2027) ($MN)
34 Global Radiopharmaceutical Market Outlook, By Erbium-169 (2018-2027) ($MN)
35 Global Radiopharmaceutical Market Outlook, By Cesium-131 (2018-2027) ($MN)
36 Global Radiopharmaceutical Market Outlook, By Actinium-225 (2018-2027) ($MN)
37 Global Radiopharmaceutical Market Outlook, By Application (2018-2027) ($MN)
38 Global Radiopharmaceutical Market Outlook, By Thyroid (2018-2027) ($MN)
39 Global Radiopharmaceutical Market Outlook, By Theranostics (2018-2027) ($MN)
40 Global Radiopharmaceutical Market Outlook, By Oncology (2018-2027) ($MN)
41 Global Radiopharmaceutical Market Outlook, By Neurology (2018-2027) ($MN)
42 Global Radiopharmaceutical Market Outlook, By Neuroendocrinology (2018-2027) ($MN)
43 Global Radiopharmaceutical Market Outlook, By Nephrology (2018-2027) ($MN)
44 Global Radiopharmaceutical Market Outlook, By Lymphoma (2018-2027) ($MN)
45 Global Radiopharmaceutical Market Outlook, By Inflammation (2018-2027) ($MN)
46 Global Radiopharmaceutical Market Outlook, By Gastroenterology (2018-2027) ($MN)
47 Global Radiopharmaceutical Market Outlook, By Cardiology (2018-2027) ($MN)
48 Global Radiopharmaceutical Market Outlook, By End User (2018-2027) ($MN)
49 Global Radiopharmaceutical Market Outlook, By Ambulatory Surgical Centers (2018-2027) ($MN)
50 Global Radiopharmaceutical Market Outlook, By Cancer Research Institute (2018-2027) ($MN)
51 Global Radiopharmaceutical Market Outlook, By Diagnostic Imaging Centers (2018-2027) ($MN)
52 Global Radiopharmaceutical Market Outlook, By Hospitals (2018-2027) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
Select License Type
WHY CHOOSE US ?

Assured Quality
Best in class reports with high standard of research integrity

24X7 Research Support
Continuous support to ensure the best customer experience.

Free Customization
Adding more values to your product of interest.

Safe & Secure Access
Providing a secured environment for all online transactions.

Trusted by 600+ Brands
Serving the most reputed brands across the world.